AT363592B - Verfahren zur isolierung und reinigung von immunologisch wirksamen polyribosylribitolphosphat - Google Patents

Verfahren zur isolierung und reinigung von immunologisch wirksamen polyribosylribitolphosphat

Info

Publication number
AT363592B
AT363592B AT0766178A AT766178A AT363592B AT 363592 B AT363592 B AT 363592B AT 0766178 A AT0766178 A AT 0766178A AT 766178 A AT766178 A AT 766178A AT 363592 B AT363592 B AT 363592B
Authority
AT
Austria
Prior art keywords
insulating
cleaning
immunologically effective
ribitol phosphate
polyribosyl ribitol
Prior art date
Application number
AT0766178A
Other languages
English (en)
Other versions
ATA766178A (de
Inventor
Joseph S-C Kuo
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Priority to AT0624980A priority Critical patent/AT369989B/de
Publication of ATA766178A publication Critical patent/ATA766178A/de
Application granted granted Critical
Publication of AT363592B publication Critical patent/AT363592B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/851—Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT0766178A 1977-10-28 1978-10-25 Verfahren zur isolierung und reinigung von immunologisch wirksamen polyribosylribitolphosphat AT363592B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0624980A AT369989B (de) 1977-10-28 1980-12-22 Verfahren zur herstellung einer kombinationsvaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
ATA766178A ATA766178A (de) 1981-01-15
AT363592B true AT363592B (de) 1981-08-10

Family

ID=25298089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0766178A AT363592B (de) 1977-10-28 1978-10-25 Verfahren zur isolierung und reinigung von immunologisch wirksamen polyribosylribitolphosphat

Country Status (4)

Country Link
US (1) US4220717A (de)
AT (1) AT363592B (de)
PH (1) PH15958A (de)
ZA (1) ZA784803B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407949A (en) * 1980-09-22 1983-10-04 Merck & Co., Inc. Meningitis vaccine
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US5360897A (en) * 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4954449A (en) * 1982-08-24 1990-09-04 The United States Of America As Represented By The Secretary Of The Army Human monoclonal antibody reactive with polyribosylribitol phosphate
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4762713A (en) * 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
ATE110965T1 (de) * 1989-03-09 1994-09-15 Praxis Biolog Inc Impfstoffe gegen hämophilus influenzae.
US5019502A (en) * 1989-06-12 1991-05-28 Merck & Company, Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5039610A (en) * 1989-06-12 1991-08-13 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5045456A (en) * 1989-06-12 1991-09-03 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
DE10142288B4 (de) * 2001-03-27 2006-04-20 Saargummi Gmbh Trägerprofil und Verbindungsbereich für Dichtungsprofile an Automobilkarosserien
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7144989B2 (en) * 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
US6737524B2 (en) * 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
ATE460498T1 (de) * 2003-09-11 2010-03-15 Staat Der Nederlanden Vert Doo Verfahren zur herstellung eines kapselpolysaccharids zur verwendung in konjugat- impfstoffen
EP2155244B1 (de) * 2007-04-23 2017-03-22 Serum Institute of India Private Limited Antigene polysaccharide und verfahren zu ihrer herstellung
CN104487086B (zh) 2012-07-07 2019-08-30 巴拉特生物技术国际有限公司 无动物源的不含酒精的疫苗组合物及其制备方法
JP6944946B2 (ja) 2016-10-20 2021-10-06 Ｋｍバイオロジクス株式会社 低分子化ＰＲＰを用いたＨｉｂコンジュゲートワクチンの製造方法
CA3052621A1 (en) 2017-02-03 2018-08-09 Schadeck, Eva Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
PH15958A (en) 1983-05-04
ZA784803B (en) 1979-08-29
ATA766178A (de) 1981-01-15
US4220717A (en) 1980-09-02

Similar Documents

Publication Publication Date Title
AT363592B (de) Verfahren zur isolierung und reinigung von immunologisch wirksamen polyribosylribitolphosphat
AT369673B (de) Verfahren zur behandlung bedenklicher abfaelle
DD138310A5 (de) Verfahren zur aethylierung von monoalkylbenzolen
DD131128A5 (de) Verfahren zur entcoffeinierung von kaffee
ATA913578A (de) Verfahren zur o-metylierung von hydroxy- aporphinen
AT366032B (de) Verfahren zur herstellung von moranolin und n-methylmoranolin
DD138673A1 (de) Verfahren zur erzeugung von formkoks
LU79083A1 (de) Verfahren zur vermeidung von abfall bei der vliesherstellung
AT356045B (de) Verfahren und vorrichtung zur vorentlaugung von hopfen
AT370997B (de) Verfahren zur gewinnung von myeloperoxidase
AT353991B (de) Verfahren zur reinigung von sekretin
ATA49278A (de) Verfahren zur hydroformylierung von alfa- -olefinen
DD137226A5 (de) Verfahren zur reinigung von mercaptobenzthiazol
AT373505B (de) Verfahren zur behandlung fremd- und schadstoffschadstoffbeladener abgasgemische
AT369035B (de) Verfahren zur erzeugung von eisenschwamm
AT365074B (de) Verfahren zur gewinnung von humanalbumin
DD131575A5 (de) Verfahren und betriebsanlage zur erzeugung von elektris
DD132963A1 (de) Verfahren zur reinigung von wasseroberflaechen
AT369013B (de) Verfahren zur hestellung von amidinophosphonaten
AT364369B (de) Verfahren zur gewinnung von cyanurchlorid
DD161124A3 (de) Verfahren zur gewinnung von glucoseisomerase
AT364371B (de) Verfahren zur gewinnung von cyanurchlorid
AT364370B (de) Verfahren zur gewinnung von cyanurchlorid
DD135994A1 (de) Verfahren und anordnung zur ausloesung lokaler lichtreizantworten
DD130180A2 (de) Verfahren zur regenerierung von eisenchelathaltigen bleichfixierbaedern

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee